in silico methods in fragment-based drug design — a Protein Kinase B case study

webinar

Wed, 28 Jan 2015, 19:00 CET (Berlin)

Dr. Alastair Donald, BioSolveIT GmbH, St. Augustin, Germany

in silico methods in fragment-based drug design — a Protein Kinase B case study

Computational tools are invaluable in the process of identifying high-quality fragment hits. In this one hour BioSolveIT webinar you will learn how to fast-track your fragment hit discovery using our cutting edge in silico solutions using Protein Kinase B as an example.

By the end you will appreciate how our suite of SBDD tools can enrich your work life, enhance your productivity and assist in the identification of potent, selective and synthetically accessible lead-like molecules.

So, if you are interested in

  • enriching your screening collection with potent and selective fragments
  • intelligently selecting which commercially available analogs to purchase
  • deciding which analogs to prioritize for synthesis
  • saving time and money by focusing on the most promising ideas

watch the video live recording below.

Current news

category
Events
BioSolveIT at 34th GP2A 2026 Conference on Medicinal Chemistry in Gothenburg
December 17, 2025 15:19 CET
BioSolveIT is honored and excited to participate in the 34th GP2A 2026 Conference on Medicinal Chemistry in Gothenburg. From August 26 to 28, 2026, the Group for the Promotion of Pharmaceutical Chemistry in Academia (GP2A), a member-led network of academic medicinal chemists working at universities and research institutes in Europe,...
Read on
BioSolveIT wrapped 2025
December 15, 2025 06:18 CET
Our Year in Drug Discovery In 2025, we focused on bridging the gap between computational prediction and compound tangibility. Along the way we refined and evolved our platforms to ensure that drug discovery is not only faster, but also more accessible and reliable for researchers everywhere. This year saw the...
Read on
category
Challenge
Emina Yekt Yilmaz Wins Scientific Challenge Winter 2024!
December 9, 2025 14:52 CET
It is our greatest pleasure to announce the winner of the Winter 2024 edition of the Scientific Challenge: the winner is Emine Yekta Yilmaz from Haceteppe and Gazi Universities (Ankara, Turkey) with her project ‘Leveraging AI and Physics-Based Screening for the Identification of sEH Inhibitors’. Based on standardized compound datasets...
Read on